Blogposts on our products, our collaborations, our news,…
Effectiveness of using the REAtouch® during intensive and functional HABIT-ILE intervention for children with unilateral cerebral palsy
We are pleased to announce the publication of a randomised controlled trial evaluating the effectiveness of an intensive and functional HABIT-ILE (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities)
First clinical evaluation of the REAtouch® Home, for a personalised, functional and long-term neurorehabilitation at home.
The team of Professor Thierry LEJEUNE, medical practitioner from the physical medicine and rehabilitation department of the Cliniques universitaires Saint-Luc, has started the first clinical evaluation of the REAtouch® Home
The REAplan® 3.4 – A new design with enhanced accessibility
At the beginning of 2023, Axinesis launches the new version of the REAplan® robot. This new 3.4 model has improved ease of use of the device thanks to an optimization
New Chief Medical Officer (CMO) started at Axinesis from the 1st of September !
Since the 1st of September, a new member has joined Axinesis. Maxime Gilliaux, physiotherapist, doctor in motor sciences and Executive MBA in health, is now our Chief Medical Officer. He
Proven effectiveness of early Robotic Assisted Therapy for upper limb rehabilitation after stroke
Study provides further evidence for the effectiveness of robot-assisted therapy in stroke upper limb rehabilitation Robot-assisted therapy (RAT) is of significant interest in early rehabilitation, when neuroplasticity is high but
The arrival of REAtouch Lite® at Axinesis
Axinesis expands its intensive functional rehabilitation offer We are delighted to announce the launch of our new REAtouch® Lite: the device for decentralized upper-limb rehabilitation in the rehabilitation centre or